Search

everythinglearnresearchcommunity

for

Search:↓

The document explains the causes, types, diagnosis, and treatments of hair loss, and its psychological impact, especially on women.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Early diagnosis and personalized treatments are crucial for better hair loss management.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Managing diabetes can lead to eating disorders, and eating disorders can make diabetes harder to control.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Some psychiatric medications can cause reversible hair loss.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

The COVID-19 pandemic increased symptoms in people with skin picking and hair pulling disorders.

Societal pressure for the perfect body leads to health risks and disorders.

Trichotillomania can cause severe complications like hairballs in the stomach, needing surgery and psychiatric care.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.